{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:19:59Z","timestamp":1787239199837,"version":"build-2736575974"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Diffuse large B-cell lymphoma (DLBCL) is a common aggressive B-cell non-Hodgkin lymphoma (B-NHL). While combined chemotherapy has improved the outcomes of DLBCL, it remains a highly detrimental disease. Pyroptosis, an inflammatory programmed cell death, is considered to have both tumor-promoting and tumor-suppressing effects. The role of pyroptosis in DLBCL has been gradually appreciated, but its value needs further investigation.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We analyzed mutations and copy number variation (CNV) alterations of pyroptosis-related genes (PRGs) from The Cancer Genome Atlas (TCGA) cohort and evaluated the differences in expression in normal B cells and DLBCL patients in two Gene Expression Omnibus (GEO) datasets (GSE12195 and GSE56315). Based on the expression of 52 PRGs, we divided 421 DLBCL patients from the GSE31312 dataset into distinct clusters using consensus clustering. The Kaplan-Meier method was used to prognosis among the three clusters, and GSVA was used to explore differences in the biological functions. ESTIMATE and single-sample gene-set enrichment analysis (ssGSEA) were used to analyze the tumor immune microenvironment (TME) in different clusters. A risk score signature was developed using a univariate survival analysis and multivariate regression analysis, and the reliability and validity of the signature were verified. By combining the signature with clinical factors, a nomogram was established to predict the prognosis of DLBCL patients. The alluvial diagram and correlation matrix were used to explore the relationship between pyroptosis risk score, clinical features and TME.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    A large proportion of PRGs are dysregulated in DLBCL and associated with the prognosis. We found three distinct pyroptosis-related clusters (cluster A, B, and C) that differed significantly with regard to the prognosis, biological process, clinical characteristics, chemotherapeutic drug sensitivity, and TME. Furthermore, we developed a risk score signature that effectively differentiates high and low-risk patients. The nomogram combining this signature with several clinical indicators showed an excellent ability to predict the prognosis of DCBCL patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    This work demonstrates that pyroptosis plays an important role in the diversity and complexity of the TME in DLBCL. The risk signature of pyroptosis is a promising predictive tool. A correct and comprehensive assessment of the mode of action of pyroptosis in individuals will help guide more effective treatment.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2021.779123","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T04:17:09Z","timestamp":1636085829000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment"],"prefix":"10.3389","volume":"9","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun-yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Li","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-da","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.it.2017.01.003","article-title":"Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions","volume":"38","author":"Aglietti","year":"2017","journal-title":"Trends Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1200\/jco.2001.19.3.720","article-title":"Cd4+ T-Cell Immune Response to Large B-Cell Non-hodgkin's Lymphoma Predicts Patient Outcome","volume":"19","author":"Ansell","year":"2001","journal-title":"Jco"},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 Receptor-NLRP3 Inflammasome Complex Predicts the Development of Non-hodgkin's Lymphoma in Sjogren's Syndrome: a Prospective, Observational, Single-centre Study","volume":"282","author":"Baldini","year":"2017","journal-title":"J. Intern. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjh.13206","article-title":"DNA Repair in Diffuse Large B-Cell Lymphoma: a Molecular Portrait","volume":"169","author":"Bret","year":"2015","journal-title":"Br. J. Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.4161\/cc.25115","article-title":"Nucleotide Excision DNA Repair Pathway as a Therapeutic Target in Patients with High-Risk Diffuse Large B Cell Lymphoma","volume":"12","author":"Bret","year":"2013","journal-title":"Cell Cycle"},{"key":"B6","article-title":"Ggalluvial: Alluvial Plots in \u2018ggplot2\u2019","author":"Brunson","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of Cancer Immunity and the Cancer-Immune Set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc. Ser. B (Methodological)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.20161707","article-title":"NLRP3 Signaling Drives Macrophage-Induced Adaptive Immune Suppression in Pancreatic Carcinoma","volume":"214","author":"Daley","year":"2017","journal-title":"J. Exp. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic Subtypes of High-Grade Bladder Cancer Reflect the Hallmarks of Breast Cancer Biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1182\/blood-2018-02-778480","article-title":"Management of Aggressive B-Cell NHLs in the AYA Population: an Adult vs Pediatric Perspective","volume":"132","author":"Dunleavy","year":"2018","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1462-5822.2006.00751.x","article-title":"Caspase-1-dependent Pore Formation during Pyroptosis Leads to Osmotic Lysis of Infected Host Macrophages","volume":"8","author":"Fink","year":"2006","journal-title":"Cell Microbiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1600-0609.2011.01649.x","article-title":"Serum Interleukin-18 Level Is Associated with the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with CHOP or R-CHOP Regimens","volume":"87","author":"Goto","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, Inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"36107","DOI":"10.1038\/srep36107","article-title":"Targeting inflammasome\/IL-1 Pathways for Cancer Immunotherapy","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene Set Variation Analysis for Microarray and RNA-Seq Data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.247.18.2543","article-title":"Evaluating the Yield of Medical Tests","volume":"247","author":"Harrell","year":"1982","journal-title":"Evaluating yield Med. tests"},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1158\/1078-0432.Ccr-15-1507","article-title":"The where, the when, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.Can-18-3962","article-title":"The Tumor Microenvironment Innately Modulates Cancer Progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.biopha.2017.08.120","article-title":"IL-1\u03b2-induced NF-\u039ab Activation Down-Regulates miR-506 Expression to Promotes Osteosarcoma Cell Growth through JAG1","volume":"95","author":"Hu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T Cell Exclusion, Immune Privilege, and the Tumor Microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","article-title":"Time-dependent ROC Curve Analysis in Medical Research: Current Methods and Applications","volume":"17","author":"Kamarudin","year":"2017","journal-title":"BMC Med. Res. Methodol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","article-title":"Blocking IL-1\u03b2 Reverses the Immunosuppression in Mouse Breast Cancer and Synergizes with Anti-PD-1 for Tumor Abrogation","volume":"116","author":"Kaplanov","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging Inflammasome Signals in Tumorigenesis and Potential Targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/modpathol.2009.98","article-title":"Sonic Hedgehog Signaling Proteins and ATP-Binding Cassette G2 Are Aberrantly Expressed in Diffuse Large B-Cell Lymphoma","volume":"22","author":"Kim","year":"2009","journal-title":"Mod. Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.7150\/thno.45631","article-title":"DNA Methylation Downregulated ZDHHC1 Suppresses Tumor Growth by Altering Cellular Metabolism and Inducing Oxidative\/ER Stress-Mediated Apoptosis and Pyroptosis","volume":"10","author":"Le","year":"2020","journal-title":"Theranostics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal Gene Signatures in Large-B-Cell Lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41419-020-03035-2","article-title":"BAFF-driven NLRP3 Inflammasome Activation in B Cells","volume":"11","author":"Lim","year":"2020","journal-title":"Cell Death Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1691\/ph.2017.6888","article-title":"IL-1\u03b2-mediated NF-\u039ab Signaling Augments the Osteosarcoma Cell Growth through Modulating miR-376c\/TGFA axis","volume":"72","author":"Liu","year":"2017","journal-title":"Pharmazie"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.18632\/aging.102291","article-title":"Downregulation of LncRNA-XIST Inhibited Development of Non-small Cell Lung Cancer by Activating miR-335\/SOD2\/ROS Signal Pathway Mediated Pyroptotic Cell Death","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2020.10.024","article-title":"NLRP3 Inflammasome Upregulates PD-L1 Expression and Contributes to Immune Suppression in Lymphoma","volume":"497","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of Inflammasome Activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 Attenuates Tumour Response to PD-L1 Blockade by Contributing to Exclusion of T Cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGF\u03b2 in Cancer","volume":"134","author":"Massagu\u00e9","year":"2008","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3324\/haematol.2019.243626","article-title":"Immune Cell Constitution in the Tumor Microenvironment Predicts the Outcome in Diffuse Large B-Cell Lymphoma","volume":"106","author":"Matias Autio","year":"2021","journal-title":"haematol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and Comprehensive Analysis of Somatic Variants in Cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ccell.2018.02.007","article-title":"Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment","volume":"33","author":"Nakamura","year":"2018","journal-title":"Cancer Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1159\/000086984","article-title":"Immunohistochemical Expression of Multidrug Resistance Proteins as a Predictor of Poor Response to Chemotherapy and Prognosis in Patients with Nodal Diffuse Large B-Cell Lymphoma","volume":"68","author":"Ohsawa","year":"2005","journal-title":"Oncology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/bjs.10238","article-title":"Kaplan-meier Curve","volume":"104","author":"Ranstam","year":"2017","journal-title":"Br. J. Surg."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.18632\/aging.103314","article-title":"LncRNA ADAMTS9-AS2 Inhibits Gastric Cancer (GC) Development and Sensitizes Chemoresistant GC Cells to Cisplatin by Regulating miR-223-3p\/NLRP3 axis","volume":"12","author":"Ren","year":"2020","journal-title":"Aging"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/s0140-6736(16)00561-4","article-title":"Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed Following Treatment with Platinum-Based Chemotherapy: a Single-Arm, Multicentre, Phase 2 Trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"The Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/jci45817","article-title":"Matrix Architecture Defines the Preferential Localization and Migration of T Cells into the Stroma of Human Lung Tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B47","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse Large B-Cell Lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor Immune Microenvironment Characterization in clear Cell Renal Cell Carcinoma Identifies Prognostic and Immunotherapeutically Relevant Messenger RNA Signatures","volume":"17","author":"\u015eenbabao\u011flu","year":"2016","journal-title":"Genome Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/s0140-6736(12)60605-9","article-title":"Non-Hodgkin Lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"The Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.2174\/092986710793176348","article-title":"Interleukin-18: Biology and Role in the Immunotherapy of Cancer","volume":"17","author":"Srivastava","year":"2010","journal-title":"Cmc"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.7150\/thno.58322","article-title":"Tumor Suppressor DRD2 Facilitates M1 Macrophages and Restricts NF-\u039ab Signaling to Trigger Pyroptosis in Breast Cancer","volume":"11","author":"Tan","year":"2021","journal-title":"Theranostics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","article-title":"Diffuse Large B-Cell Lymphoma (DLBCL): ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann. Oncol."},{"key":"B54","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Villanueva","year":"2019"},{"key":"B55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jsb.2017.08.001","article-title":"AIM2 Inflammasome Activation and Regulation: A Structural Perspective","volume":"200","author":"Wang","year":"2017","journal-title":"J. Struct. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/labinvest.2013.126","article-title":"Deregulation of the NLRP3 Inflammasome in Hepatic Parenchymal Cells during Liver Cancer Progression","volume":"94","author":"Wei","year":"2014","journal-title":"Lab. Invest."},{"key":"B57","first-page":"e24","volume":"56","author":"Wei","year":"2017","journal-title":"Package \u2018corrplot\u2019"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a Class Discovery Tool with Confidence Assessments and Item Tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.4049\/jimmunol.1402098","article-title":"The NLRP1 Inflammasome Attenuates Colitis and Colitis-Associated Tumorigenesis","volume":"194","author":"Williams","year":"2015","journal-title":"J.I."},{"key":"B60","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41419-019-1883-8","article-title":"The Role of Pyroptosis in Cancer: Pro-cancer or Pro-\"host","volume":"10","author":"Xia","year":"2019","journal-title":"Cel Death Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41420-021-00451-x","article-title":"A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer","volume":"7","author":"Ye","year":"2021","journal-title":"Cell Death Discov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/10245332.2017.1312205","article-title":"Upregulation of ADAM12 Contributes to Accelerated Cell Proliferation and Cell Adhesion-Mediated Drug Resistance (CAM-DR) in Non-hodgkin's Lymphoma","volume":"22","author":"Yin","year":"2017","journal-title":"Hematology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring Tumour Purity and Stromal and Immune Cell Admixture from Expression Data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","article-title":"RCircos: an R Package for Circos 2D Track Plots","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/hep.29681","article-title":"Hypoxia-inducible Factor-1\u03b1\/interleukin-1\u03b2 Signaling Enhances Hepatoma Epithelial-Mesenchymal Transition through Macrophages in a Hypoxic-Inflammatory Microenvironment","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1158\/2326-6066.Cir-20-0525","article-title":"Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity","volume":"9","author":"Zhang","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.18632\/oncotarget.21010","article-title":"NLRP3 Inflammasome Activation Plays a Carcinogenic Role through Effector Cytokine IL-18 in Lymphoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"B68","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T Cells, Tumour Immunity and Immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.779123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T04:17:15Z","timestamp":1636085835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.779123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":68,"alternative-id":["10.3389\/fcell.2021.779123"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.779123","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"article-number":"779123"}}